Earnings call transcript: L’Oréal Q1 2026 shows strong growth amid IT challenges

The setup is better for the premium end of beauty than the headline market implies. When selective and dermo are taking share in China while Europe remains resilient, the key second-order effect is that mix is improving even if unit growth moderates; that supports pricing power and offsets some tariff/oil leakage. The biggest winner is not the market leader per se, but brands with enough innovation cadence to keep consumers trading up despite a softer macro backdrop.

The operational drag from the IT transition matters more for near-term sell-side estimates than for franchise value. A few hundred basis points of timing noise can mask true momentum, and that creates an opportunity in names where investors over-penalize reported growth while the underlying sell-out is accelerating. The more important risk is a compounding effect in the U.S.: if inventory prebuilds ahead of systems migration coincide with freight/oil inflation, reported margins can look worse for 1-2 quarters even if demand stays intact.

The market is underappreciating how much of the growth story is being pulled by channels and categories that are less cyclical than discretionary beauty at first glance: premium haircare, dermo, and prestige fragrance. That tends to compress volatility in the earnings stream and should support multiple durability. The main contrarian risk is that consensus is extrapolating a China rebound too quickly; if the selective premium recovery stalls, the mix tailwind fades and the stock can de-rate even with decent top-line growth. For peers, the Kering beauty transition is more of a medium-term competitive threat than an immediate earnings driver, but it increases the odds of portfolio reshuffling and more aggressive licensing competition across fragrance and luxury skincare.